Group B:Dexamethasone+5-Hydroxytryptamine Receptor 3 Antagonists

2 trials

Sponsors

West China Hospital, Sichuan University

Conditions

tumor

Phase 4

A randomized, double-blind, controlled, multicenter prospective clinical trial of Huoxiang Zhengqi Oral Liquid to prevent chemotherapy-induced nausea and vomiting following platinum-containing multi-day chemotherapy

Active, not recruitingITMCTR2000004069

West China Hospital, Sichuan Universitytumor

Start: 2020-12-01Updated: 2023-02-20

A randomized, double-blind, controlled, multicenter prospective clinical trial of Huoxiang Zhengqi Oral Liquid to prevent chemotherapy-induced nausea and vomiting following platinum-containing multi-day chemotherapy

Active, not recruitingChiCTR2000040123

West China Hospital, Sichuan Universitytumor

Start: 2020-12-01Updated: 2021-01-11

Related Papers

Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial

Journal of Integrative and Complementary Medicine2023-03-315 citations